Quadrant Capital Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,611
| Closed | -$22.4K | – | 1452 |
|
|
2025
Q1 | $22.4K | Buy |
2,611
+450
| +21% | +$3.86K | ﹤0.01% | 2007 |
|
|
2024
Q4 | $23.2K | Buy |
2,161
+649
| +43% | +$6.97K | ﹤0.01% | 1824 |
|
|
2024
Q3 | $8.59K | Hold |
1,512
| – | – | ﹤0.01% | 2184 |
|
|
2024
Q2 | $6.38K | Buy |
+1,512
| New | +$6.38K | ﹤0.01% | 2237 |
|
|
2024
Q1 | – | Sell |
-86
| Closed | -$801 | – | 2721 |
|
|
2023
Q4 | $801 | Buy |
+86
| New | +$801 | ﹤0.01% | 2573 |
|
|
2018
Q1 | – | Sell |
-1,705
| Closed | -$5K | – | 2160 |
|
|
2017
Q4 | $5K | Hold |
1,705
| – | – | ﹤0.01% | 1446 |
|
|
2017
Q3 | $7K | Hold |
1,705
| – | – | ﹤0.01% | 1318 |
|
|
2017
Q2 | $9K | Hold |
1,705
| – | – | ﹤0.01% | 1132 |
|
|
2017
Q1 | $9K | Hold |
1,705
| – | – | ﹤0.01% | 1102 |
|
|
2016
Q4 | $6K | Buy |
+1,705
| New | +$6K | ﹤0.01% | 1175 |
|